A Multipeptide Vaccine is Safe and Elicits T-cell Responses in Participants With Advanced Stage Ovarian Cancer

Author:

Chianese-Bullock Kimberly A.,Irvin William P.,Petroni Gina R.,Murphy Cheryl,Smolkin Mark,Olson Walter C.,Coleman Elizabeth,Boerner Scott A.,Nail Carmel J.,Neese Patrice Y.,Yuan Arlene,Hogan Kevin T.,Slingluff Craig L.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology,Immunology,Immunology and Allergy

Reference45 articles.

1. Cancer statistics, 2007;Jemal;CA Cancer J Clin,2007

2. Study of HLA class I restriction and the directed antigens of cytotoxic T lymphocytes at the tumor sites of ovarian cancer;Yamada;Cancer Immunol Immunother,1999

3. Generation and phenotypic characterization of new human ovarian cancer cell lines with the identification of antigens potentially recognizable by HLA-restricted cytotoxic T cells;Ramakrishna;Int J Cancer,1997

4. Effects of irradiation on the expression of surface antigens in human ovarian cancer;Santin;Gynecol Oncol,1996

5. Trophoblast and ovarian cancer antigen LK26. Sensitivity and specificity in immunopathology and molecular identification as a folate binding protein;Garin-Chesea;Am J Pathol,1993

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3